Announcements
Cardiovascular Drugs
Section Information
NO
Special Issue
Following special issues within this section are currently open for submission.
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors Show a Growing Promise within the Field of Cardiology
Guest Editors: Robert J. Chilton, Badr HarfouchKeywords: heart failure; coronary atherosclerosis; diabetes mellitus; SGLT-2 inhibitors; GLP-1 RA; cardiovascular disease; cardiologySubmission deadline: 30 June 2024Advances in Pharmacological Treatments of Acute Coronary Syndromes - version 2.0
Guest Editor: Pietro ScicchitanoKeywords: acute coronary syndrome; cardiovascular pharmacology; target therapies; vascular biology; metabolomics; advances in therapiesSubmission deadline: 30 April 2024Advances of Drug Therapy in Heart Failure
Guest Editor: Massimo IacovielloKeywords: heart failure; drug therapy; prognosis; cardiomyopathies, cardiovascular ımaging; arrhythmiasSubmission deadline: 31 January 2024
Click here to see the full Special Issues‘ list of “Cardiovascular Drugs”.
Paper Published
Click here a list of 13 papers published in this section.